Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology ROE 2010-2024 | POAI

Current and historical return on equity (ROE) values for Predictive Oncology (POAI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Predictive Oncology ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-06-30 $-0.01B $0.00B -185.71%
2024-03-31 $-0.01B $0.00B -143.59%
2023-12-31 $-0.01B $0.01B -96.30%
2023-09-30 $-0.02B $0.01B -105.88%
2023-06-30 $-0.02B $0.02B -88.37%
2023-03-31 $-0.03B $0.02B -95.24%
2022-12-31 $-0.03B $0.02B -81.30%
2022-09-30 $-0.03B $0.03B -70.92%
2022-06-30 $-0.03B $0.03B -65.41%
2022-03-31 $-0.02B $0.04B -42.70%
2021-12-31 $-0.02B $0.04B -45.20%
2021-09-30 $-0.02B $0.05B -65.71%
2021-06-30 $-0.03B $0.05B -96.15%
2021-03-31 $-0.03B $0.04B -165.08%
2020-12-31 $-0.03B $0.00B -291.89%
2020-09-30 $-0.03B $0.01B -266.67%
2020-06-30 $-0.03B $0.01B -200.00%
2020-03-31 $-0.02B $0.01B -137.50%
2019-12-31 $-0.02B $0.01B -148.15%
2019-09-30 $-0.01B $0.02B -83.72%
2019-06-30 $-0.01B $0.02B -128.00%
2019-03-31 $-0.01B $0.00B -733.33%
2018-12-31 $-0.01B $0.00B -363.64%
2018-09-30 $-0.01B $0.00B -228.57%
2018-06-30 $-0.01B $0.00B -184.62%
2018-03-31 $-0.01B $0.01B -215.38%
2017-12-31 $-0.01B $0.00B -200.00%
2017-09-30 $-0.01B $0.00B -240.00%
2017-06-30 $-0.01B $0.00B -300.00%
2017-03-31 $-0.01B $0.00B -400.00%
2016-12-31 $-0.01B $0.00B -560.00%
2016-09-30 $-0.01B $0.00B -400.00%
2016-06-30 $-0.01B $0.00B -228.57%
2016-03-31 $-0.01B $0.00B -342.86%
2015-12-31 $-0.00B $0.00B 800.00%
2015-09-30 $-0.00B $0.01B 133.33%
2015-06-30 $-0.00B $-0.01B 72.73%
2015-03-31 $-0.01B $-0.01B 105.26%
2014-12-31 $-0.01B $-0.01B 186.67%
2014-09-30 $-0.01B $-0.00B 233.33%
2014-06-30 $-0.01B $-0.00B 444.44%
2014-03-31 $-0.01B $-0.00B 400.00%
2013-12-31 $-0.01B $-0.00B 360.00%
2013-09-30 $-0.01B $-0.00B 360.00%
2013-06-30 $-0.01B $-0.00B 290.91%
2013-03-31 $-0.01B $-0.00B 360.00%
2012-12-31 $-0.01B $-0.00B 320.00%
2012-09-30 $-0.01B $-0.00B 360.00%
2012-06-30 $-0.01B $-0.00B 280.00%
2012-03-31 $-0.01B $-0.00B 200.00%
2011-12-31 $-0.00B $-0.00B 177.78%
2011-09-30 $-0.00B $-0.00B 50.00%
2011-06-30 $0.00B $-0.00B 0.00%
2011-03-31 $0.00B $-0.00B 0.00%
2010-12-31 $-0.00B $-0.00B 50.00%
2010-09-30 $-0.00B $-0.00B 50.00%
2010-06-30 $-0.00B $-0.00B 100.00%
2010-03-31 $-0.00B $-0.00B 200.00%
2009-12-31 $-0.00B $-0.00B 300.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.005B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Hims & Hers Health (HIMS) United States $5.988B 154.89
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00